Sponsor or institution
Clinical trials and research at National Medical Research Radiological Centre of the Ministry of Health of Russia
As of November 12, 2026, Find a Trial lists 5 clinical trials run by National Medical Research Radiological Centre of the Ministry of Health of Russia that are recruiting, in Russia. 1 was first registered in the last 30 days. By phase: Phase 2 (2), Phase 1 (2), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Intra-arterial Y-90 Radioembolization for unresectable pancreatic cancer | Phase 1 | Obninsk | Recruiting | Oct 27, 2026 |
| Preoperative Proton Therapy for High-Grade Brain Tumors | Phase 1 | Obninsk, Kaluga Oblast | Recruiting | Jul 17, 2026 |
| Using nivolumab with AVD for advanced Hodgkin lymphoma | Phase 2 | Moscow | Recruiting | May 22, 2025 |
| Stereotactic radiation therapy for patients with 6 to 10 metastatic sites | Phase 2 | Obninsk, Kaluga Oblast | Recruiting | Mar 4, 2025 |
| Stereotactic radiotherapy for patients with oligometastatic cancer | Phase 2/3 | Obninsk, Kaluga Oblast | Recruiting | Aug 16, 2024 |
All recruiting trials (5)
-
Intra-arterial Y-90 Radioembolization for unresectable pancreatic cancer
This study tests whether delivering Yttrium-90 microspheres directly into the arteries feeding unresectable pancreatic tumors is safe and tolerable while looking for early signs of effect.
-
Preoperative Proton Therapy for High-Grade Brain Tumors
This trial tests whether giving proton therapy before surgery is tolerable for people with high-grade brain gliomas.
-
Using nivolumab with AVD for advanced Hodgkin lymphoma
This study is testing if a new combination of nivolumab and AVD chemotherapy can help people with newly diagnosed advanced Hodgkin lymphoma feel better and respond well to treatment.
-
Stereotactic radiation therapy for patients with 6 to 10 metastatic sites
This study is testing a new type of targeted radiation therapy for people with metastatic cancer who have 6 to 10 tumor sites to see if it can help them live longer.
-
Stereotactic radiotherapy for patients with oligometastatic cancer
This study tests whether a special type of targeted radiation therapy can help people with a few metastatic tumors feel better compared to standard care after chemotherapy.
Quick answers
How many clinical trials run by National Medical Research Radiological Centre of the Ministry of Health of Russia are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Russia. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.